{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:15:14Z","timestamp":1765610114000,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>According to the guidelines for cardiogenic shock, norepinephrine is associated with fewer arrhythmias than dopamine and may be the better first-line vasopressor agent. This study aimed to evaluate the utility of norepinephrine vs. dopamine as first-line vasopressor agent for cardiovascular shock depending on the presence and severity of renal dysfunction at hospitalization. This was a secondary analysis of the prospective, multicenter Japanese Circulation Society Cardiovascular Shock Registry (JCS Shock Registry) conducted between 2012 and 2014, which included patients with shock complicating emergency cardiovascular disease at hospital arrival. The analysis included 240 adult patients treated with norepinephrine alone (<jats:italic>n<\/jats:italic> = 98) or dopamine alone (<jats:italic>n<\/jats:italic> = 142) as the first-line vasopressor agent. Primary endpoint was mortality at 30 days after hospital arrival. The two groups had similar baseline characteristics, including estimated glomerular filtration rate (eGFR), and similar 30-day mortality rates. The analysis of the relationship between 30-day mortality rate after hospital arrival and vasopressor agent used in patients categorized according to the eGFR-based chronic kidney disease classification revealed that norepinephrine as the first-line vasopressor agent might be associated with better prognosis of cardiovascular shock in patients with mildly compromised renal function at admission (0.0 vs. 22.6%; <jats:italic>P<\/jats:italic> = 0.010) and that dopamine as the first-line vasopressor agent might be beneficial for cardiovascular shock in patients with severely compromised renal function [odds ratio; 0.22 (95% confidence interval 0.05\u20130.88; <jats:italic>P<\/jats:italic> = 0.032)]. Choice of first-line vasopressor agent should be based on renal function at hospital arrival for patients in cardiovascular shock.<\/jats:p><jats:p><jats:bold>Clinical Trial Registration:<\/jats:bold><jats:ext-link>http:\/\/www.umin.ac.jp\/ctr\/<\/jats:ext-link>, Unique identifier: 000008441.<\/jats:p>","DOI":"10.3389\/fmed.2021.648824","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T04:53:15Z","timestamp":1620017595000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Treatment With Vasopressor Agents for Cardiovascular Shock Patients With Poor Renal Function; Results From the Japanese Circulation Society Cardiovascular Shock Registry"],"prefix":"10.3389","volume":"8","author":[{"given":"Tsukasa","family":"Yagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eizo","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Yonemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamichi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigemasa","family":"Tani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3109\/0886022X.2011.605531","article-title":"Kidney function and histological damage in autopsy subjects with myocardial infarction","volume":"33","author":"Niizuma","year":"2011","journal-title":"Ren Fail."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertension."},{"key":"B6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1007\/s00134-005-2688-z","article-title":"Hemodynamic variables related to outcome in septic shock","volume":"31","author":"Varpula","year":"2005","journal-title":"Intensive Care Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s00134-009-1448-x","article-title":"The significance of non-sustained hypotension in emergency department patients with sepsis","volume":"35","author":"Marchick","year":"2009","journal-title":"Intensive Care Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American heart association","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1056\/NEJMra1208943","article-title":"Circulatory shock","volume":"369","author":"Vincent","year":"2013","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1253\/circj.CJ-16-0125","article-title":"Characteristics and predictors of mortality in patients with cardiovascular shock in japan- results from the Japanese circulation society cardiovascular shock registry","volume":"80","author":"Ueki","year":"2016","journal-title":"Circ J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.jcin.2014.06.017","article-title":"Outcomes in patients with cardiogenic shock following percutaneous coronary intervention in the contemporary era: an analysis from the BCIS database (British Cardiovascular Intervention Society)","volume":"7","author":"Kunadian","year":"2014","journal-title":"JACC Cardiovasc Interv."},{"key":"B13","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ahj.2009.08.005","article-title":"Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery","volume":"158","author":"Katz","year":"2009","journal-title":"Am Heart J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S1875-2136(08)71800-X","article-title":"Medium-term survival after primary angioplasty for myocardial infarction complicated by cardiogenic shock after the age of 75 years","volume":"101","author":"Samadi","year":"2008","journal-title":"Arch Cardiovasc Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0002-9343(01)01070-1","article-title":"Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction","volume":"112","author":"Koreny","year":"2002","journal-title":"Am J Med."},{"key":"B16","first-page":"S455","article-title":"Vasopressor and inotropic support in septic shock: an evidence-based review","volume-title":"Crit Care Med.","author":"Beale","year":"2004"},{"key":"B17","first-page":"47G","article-title":"Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes","volume-title":"Am J Cardiol.","author":"Bayram","year":"2005"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1253\/circj.CJ-18-1323","article-title":"Prognostic value of neurological status on hospital arrival for short-term outcome in patients with cardiovascular shock- sub-analysis of the Japanese circulation society cardiovascular shock registry","volume":"83","author":"Ueki","year":"2019","journal-title":"Circ J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00380-019-01354-9","article-title":"Clinical characteristics and prognostic factors in acute coronary syndrome patients complicated with cardiogenic shock in Japan: analysis from the Japanese circulation society cardiovascular shock registry","volume":"34","author":"Sakamoto","year":"2019","journal-title":"Heart Vessels"},{"key":"B20","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ahj.2010.06.024","article-title":"A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK trial and registry","volume":"160","author":"Sleeper","year":"2010","journal-title":"Am Heart J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/aas.12780","article-title":"Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure","volume":"60","author":"Moller","year":"2016","journal-title":"Acta Anaesthesiol Scand."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1161\/STROKEAHA.109.550707","article-title":"Relationship between blood pressure category and incidence of stroke and myocardial infarction in an urban Japanese population with and without chronic kidney disease: the Suita Study","volume":"40","author":"Kokubo","year":"2009","journal-title":"Stroke."},{"key":"B24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1053\/j.ajkd.2009.06.034","article-title":"Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study","volume":"55","author":"Nakano","year":"2010","journal-title":"Am J Kidney Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1523-1755.2005.00397.x","article-title":"Chronic kidney disease and cardiovascular disease in a general Japanese population: the hisayama study","volume":"68","author":"Ninomiya","year":"2005","journal-title":"Kidney Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archinte.164.6.659","article-title":"Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization","volume":"164","author":"Keith","year":"2004","journal-title":"Arch Intern Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: the United Kingdom prospective diabetes study (UKPDS 64)","volume":"63","author":"Adler","year":"2003","journal-title":"Kidney Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1097\/00003246-200108000-00005","article-title":"Use of dopamine in acute renal failure: a meta-analysis","volume":"29","author":"Kellum","year":"2001","journal-title":"Crit Care Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.648824\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T04:53:18Z","timestamp":1620017598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.648824\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":29,"alternative-id":["10.3389\/fmed.2021.648824"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.648824","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"article-number":"648824"}}